These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 9817189

  • 21. [Renal complications of diabetes].
    Tielemans C.
    Rev Med Brux; 1995; 16(4):258-61. PubMed ID: 7481238
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes.
    Moriyama T, Oka K, Ueda H, Imai E.
    Clin Exp Nephrol; 2004 Sep; 8(3):230-6. PubMed ID: 15480900
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A perspective on converting enzyme inhibitors and calcium channel antagonists in diabetic renal disease.
    Valentino VA, Wilson MD, Weart W, Bakris GL.
    Arch Intern Med; 1991 Dec; 151(12):2367-72. PubMed ID: 1746992
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Patterns of renal injury in NIDDM patients with microalbuminuria.
    Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G, Nosadini R.
    Diabetologia; 1996 Dec; 39(12):1569-76. PubMed ID: 8960844
    [Abstract] [Full Text] [Related]

  • 31. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
    Ruggenenti P, Mosconi L, Sangalli F, Casiraghi F, Gambara V, Remuzzi G, Remuzzi A.
    Kidney Int; 1999 Mar; 55(3):984-94. PubMed ID: 10027935
    [Abstract] [Full Text] [Related]

  • 32. [Hypertension treatment in patients with diabetes].
    Duława J.
    Przegl Lek; 1997 Mar; 54(11):777-80. PubMed ID: 9501688
    [Abstract] [Full Text] [Related]

  • 33. Renal protection in diabetes--an emerging role for calcium antagonists.
    Parving HH, Tarnow L, Rossing P.
    Cardiology; 1997 Mar; 88 Suppl 3():56-62. PubMed ID: 9397296
    [Abstract] [Full Text] [Related]

  • 34. Renal vascular effects of calcium channel blockers in hypertension.
    Benstein JA, Dworkin LD.
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):305S-312S. PubMed ID: 2078317
    [Abstract] [Full Text] [Related]

  • 35. Renal protection in diabetes: an emerging role for calcium antagonists.
    Parving HH, Tarnow L, Rossing P.
    J Hypertens Suppl; 1996 Nov; 14(4):S21-5. PubMed ID: 8986939
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of antihypertensive therapy in decreasing renal and cardiovascular complications in diabetes mellitus.
    Nosadini R, Abaterusso C, Dalla Vestra M, Bortoloso E, Saller A, Bruseghin M, Sfriso A, Trevisan M.
    Nephrol Dial Transplant; 1998 Nov; 13 Suppl 8():44-8. PubMed ID: 9870425
    [Abstract] [Full Text] [Related]

  • 37. Calcium channel blockers: do they offer renal protection?
    Reams GP.
    J Hum Hypertens; 1993 Jun; 7(3):211-9. PubMed ID: 8345486
    [Abstract] [Full Text] [Related]

  • 38. Calcium channel blockers. Progression of renal disease.
    Krishna GG, Narins RG.
    Circulation; 1989 Dec; 80(6 Suppl):IV47-51. PubMed ID: 2688984
    [Abstract] [Full Text] [Related]

  • 39. Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?
    Komers R, Anderson S.
    Curr Opin Nephrol Hypertens; 2000 Mar; 9(2):173-9. PubMed ID: 10757223
    [Abstract] [Full Text] [Related]

  • 40. Calcium antagonists and the diabetic hypertensive patient.
    Parving HH, Rossing P.
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):47-52. PubMed ID: 8503435
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.